Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

773 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter study of ocular inflammation after COVID-19 vaccination.
Yasaka Y, Hasegawa E, Keino H, Usui Y, Maruyama K, Yamamoto Y, Kaburaki T, Iwata D, Takeuchi M, Kusuhara S, Takase H, Nagata K, Yanai R, Kaneko Y, Iwahashi C, Fukushima A, Ohguro N, Sonoda KH; JOIS Uveitis Survey Working Group. Yasaka Y, et al. Among authors: fukushima a. Jpn J Ophthalmol. 2023 Jan;67(1):14-21. doi: 10.1007/s10384-022-00962-9. Epub 2022 Nov 22. Jpn J Ophthalmol. 2023. PMID: 36417027 Free PMC article.
Questionnaire survey among ophthalmic allergists on dupilumab-associated ocular surface disease in Japan.
Shoji J, Asada Y, Adachi R, Inada N, Uchio E, Kataoka Y, Katoh N, Kishimoto T, Shimizu E, Sumi T, Takamura E, Namba K, Hara Y, Harada K, Hirota A, Fukushima A, Fukuda K, Fujishima H, Matsuzawa M, Matsuda A, Mimura T, Miyazaki D, Yazu H, Yamamoto K, Kitsu K, Ebihara N. Shoji J, et al. Among authors: fukushima a. Allergol Int. 2024 Nov 29:S1323-8930(24)00121-7. doi: 10.1016/j.alit.2024.10.004. Online ahead of print. Allergol Int. 2024. PMID: 39613674 Free article. No abstract available.
Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study.
Tanihara H, Yamamoto T, Aihara M, Koizumi N, Fukushima A, Kawakita K, Kojima S, Nakamura T, Suganami H; K-232 Clinical Study Group. Tanihara H, et al. Among authors: fukushima a. Graefes Arch Clin Exp Ophthalmol. 2024 Aug;262(8):2579-2591. doi: 10.1007/s00417-024-06388-y. Epub 2024 Mar 2. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 38430227 Free PMC article. Clinical Trial.
Minimal Clinically Important Differences With the Outcomes of the App-Based Japanese Allergic Conjunctival Diseases Quality of Life Questionnaire: Cross-Sectional Observational Study.
Nagino K, Sung J, Midorikawa-Inomata A, Akasaki Y, Adachi T, Ebihara N, Fukuda K, Fukushima A, Fujio K, Okumura Y, Eguchi A, Fujimoto K, Shokirova H, Yee A, Morooka Y, Huang T, Hirosawa K, Nakao S, Kobayashi H, Inomata T. Nagino K, et al. Among authors: fukushima a. JMIR Form Res. 2024 Nov 26;8:e60731. doi: 10.2196/60731. JMIR Form Res. 2024. PMID: 39591609 Free PMC article.
Scoping Review of Virtual Reality (VR)-Based Disaster Mitigation Education.
Kimura R, Fukushima A, Kajiwara K, Sakuramoto H, Yoshihara S, Harada K, Nakayama T, Ito A. Kimura R, et al. Among authors: fukushima a. Cureus. 2024 Nov 20;16(11):e74062. doi: 10.7759/cureus.74062. eCollection 2024 Nov. Cureus. 2024. PMID: 39712731 Free PMC article. Review.
773 results